Literature DB >> 23222045

Human papillomavirus type 16 causes larger colposcopic lesions than other HPV types in patients with grade 3 cervical intraepithelial neoplasia.

Kyehyun Nam1, Jeongja Kwak, Jeongsig Kim, Seob Jeon.   

Abstract

OBJECTIVE: Recent studies have shown that human papillomavirus (HPV) type 16 causes more definite visual abnormalities on cervigram than other HPV types and is thus easier to evaluate colposcopically. We examined factors, including HPV-16, related to colposcopic lesions in patients with grade 3 cervical intraepithelial neoplasia (CIN 3).
METHODS: A retrospective chart review included 108 women with CIN 3 who underwent the loop electrosurgical excision procedure (LEEP). Lesions were assessed according to the number of cervical quadrant(s) involved by colposcopy, dichotomized as 2 or fewer or 3 or more quadrants involved. The Hybrid Capture 2 (HC2) test and HPV DNA chip assay (MyGene Co, Seoul, Korea) were used to detect HPV before punch biopsy or loop electrosurgical excision procedure. The type of HPV was dichotomized as HPV-16 or other (including negative cases). The HC2 viral load cutoff was 300 relative light units. Cytology was dichotomized as (1) low grade, less than, or equal to low-grade squamous lesions; or (2) high-grade, with high-grade squamous lesions or worse. Age and menopausal status were also assessed.
RESULTS: The mean (SD) age of the 108 women was 41.9 (10.7) years (range = 22-76 y). Seventy-one (65.7%) had lesions involving 2 quadrants or fewer and 37 (34.3%) had lesions involving 3 quadrants or more. Multiple logistic regression revealed that larger lesions (≥3 quadrants involved) were significantly associated with HPV-16 (p = .032, odds ratio [OR] = 2.552, 95% confidence interval = 1.085-6.000) but not with age, menopausal status, cytologic grade, or HPV HC2 viral load.
CONCLUSIONS: Our data suggest that colposcopic lesions differ according to HPV type and that HPV-16 is associated with larger lesions, facilitating lesion detection by colposcopy.

Entities:  

Mesh:

Year:  2013        PMID: 23222045     DOI: 10.1097/LGT.0b013e31825afd5b

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  5 in total

1.  Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE Cohort.

Authors:  Anna Gottschlich; Dirk van Niekerk; Laurie W Smith; Lovedeep Gondara; Joy Melnikow; Darrel A Cook; Marette Lee; Gavin Stuart; Ruth E Martin; Stuart Peacock; Eduardo L Franco; Andrew Coldman; Mel Krajden; Gina Ogilvie
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-20       Impact factor: 4.254

2.  Necessity for subsequent surgery in women of child-bearing age with positive margins after conization.

Authors:  Xinmei Wang; Juan Xu; Yang Gao; Pengpeng Qu
Journal:  BMC Womens Health       Date:  2021-05-07       Impact factor: 2.809

3.  Distribution of cervical intraepithelial neoplasia on the cervix in Chinese women: pooled analysis of 19 population based screening studies.

Authors:  Yu-qian Zhao; Irene J Chang; Fang-hui Zhao; Shang-ying Hu; Jennifer S Smith; Xun Zhang; Shu-min Li; Ping Bai; Wen-hua Zhang; You-lin Qiao
Journal:  BMC Cancer       Date:  2015-06-27       Impact factor: 4.430

4.  Visual appearance of the uterine cervix differs on the basis of HPV type status in high-grade squamous intraepithelial lesion: the results of a reliable method.

Authors:  Qi Zhou; Yingxin Gong; Xiangmei Qiu; Long Sui; Hongwei Zhang; Yan Wang; Lin Lin; Wenjing Diao; Yanyun Li
Journal:  BMC Womens Health       Date:  2022-01-30       Impact factor: 2.809

Review 5.  Colposcopy at a turning point.

Authors:  Kyehyun Nam
Journal:  Obstet Gynecol Sci       Date:  2017-12-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.